Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form

International Journal of Cancer

Volumn 129, Issue 4, 2011, Pages 791-798

  Mongaret, C ^a   Alexandre, J ^a,b   Thomas Schoemann, A ^a   Bermudez, E ^a   Chereau C ^a   Nicco, C ^a   Goldwasser, F ^a,b   Weill, B ^a   Batteux, F ^a   Lemare, F ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

ADAM9 S; invasion; oxidative stress

Indexed keywords

ADAM PROTEIN; HYDROGEN PEROXIDE; PROTEIN ADAM9; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADHERENT CELL; ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD29; BIOCOMPATIBLE MATERIALS; BLOTTING, WESTERN; CELL MEMBRANE; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN PEROXIDE; LAMININ; LUNG NEOPLASMS; MEMBRANE PROTEINS; METALLOPROTEASES; OXIDANTS; OXIDATIVE STRESS; PROTEIN ISOFORMS; PROTEOGLYCANS; RNA, SMALL INTERFERING;

EID: 79959709904     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25746     Document Type: Article

References (23)

1. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J,. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661-4. (Pubitemid 351928347)
2. Mori K, Shibanuma M, Nose K,. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004; 64: 7464-72. (Pubitemid 39372089)
3. Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P,. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 2009; 69: 2375-83.
4. Laurent A, Nicco C, Chéreau C, Goulvestre C, Alexandre J, Alves A, Lévy E, Goldwasser F, Panis Y, Soubrane O, Weill B, Batteux F,. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005; 65: 948-56. (Pubitemid 40216456)
5. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK,. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008; 68: 1777-85. (Pubitemid 351416563)
6. Duffy MJ, McKiernan E, O'Donovan N, McGowan PM,. Role of ADAMs in cancer formation and progression. Clin Cancer Res 2009; 15: 1140-4.
7. Handsley MM, Edwards DR,. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005; 115: 849-60. (Pubitemid 40791824)
8. Mochizuki S, Okada Y,. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007; 98: 621-28. (Pubitemid 46563436)
9. Murphy G,. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008; 8: 929-41.
10. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ,. Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 2003; 105: 754-61. (Pubitemid 36706097)
11. Grützmann R, Lüttges J, Sipos B, Ammerpohl O, Dobrowolski F, Alldinger I, Kersting S, Ockert D, Koch R, Kalthoff H, Schackert HK, Saeger HD, et al,. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer 2004; 90: 1053-58. (Pubitemid 38495828)
12. Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, Anderson C, Johnstone P, et al,. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res 2006; 66: 9519-26. (Pubitemid 44623650)
13. Fritzsche FR, Jung M, Tölle A, Wild P, Hartmann A, Wassermann K, Rabien A, Lein M, Dietel M, Pilarsky C, Calvano D, Grützmann R, et al,. ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer. Eur Urol 2008; 54: 1097-106.
14. Zigrino P, Mauch C, Fox JW, Nischt R,. Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 2005; 116: 853-59. (Pubitemid 41209190)
15. Nath D, Slocombe PM, Webster A, Stephens PE, Docherty AJ, Murphy G,. Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1) integrin, leading to a marked induction of fibroblast cell motility. J Cell Sci 2000; 113: 2319-28. (Pubitemid 30426845)
16. Karadag A, Zhou M, Croucher PI,. ADAM-9 (MDC-9/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin. Blood 2006; 107: 3271-8.
17. Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW,. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate 2007; 67: 722-31. (Pubitemid 46709441)
18. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A,. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 2005; 65: 4728-38. (Pubitemid 40740809)
19. Brill A, Chauhan AK, Canault M, Walsh MT, Bergmeier W, Wagner DD,. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res 2009; 84: 137-44.
20. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N,. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 2004; 64: 4190-96. (Pubitemid 38802422)
21. Ijkstra A, Postma DS, Noordhoek JA, Lodewijk ME, Kauffman HF, ten Hacken NH, Timens W,. Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung. Virchows Arch 2009; 454: 441-49.
22. Fong YC, Hsu SF, Wu CL, Li TM, Kao ST, Tsai FJ, Chen WC, Liu SC, Wu CM, Tang CH,. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells. Lung Cancer 2009; 64: 13-21.
23. Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW,. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate, 2010.